ASA, Partners, respond to Executive Order on America’s Supply Chain

On April 12, the American Society of Anesthesiologists (ASA) - in partnership with the American Hospital Association, the American Medical Association, the American Society of Health-System Pharmacists, the Association for Clinical Oncology, and United States Pharmacopeia - responded to the Biden Administration’s Executive Order (EO) 14017. This executive order serves as an important step in further addressing drug shortages and supply issues related to personal protective equipment (PPE), in particular . 

Among ongoing challenges that include natural disasters, quality problems, and manufacturer consolidation, the current COVID-19 pandemic has underscored the vulnerability of the healthcare supply chain in the United States. The pandemic has demonstrated the continued need to identify and rectify the fragilities and deficiencies in the supply chain.

ASA and its partner organizations have long committed to a collaborative approach to strengthening supply chains and increasing transparency in the U.S. and global regulatory system, most recently convening with the July 2020 joint summit on the U.S. pharmaceutical supply chain and the September 2018 ASA-led Drug Shortages Summit. 

ASA applauds the Biden Administration for its focus on supply chain security and offers its assistance to the Department of Health and Human Services with regard to implementation of EO 14017 and future supply chain policy changes.

Click here to read the letter